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These have in fact been incorporated into the SAMDC's
latest set of guidelines.
So, with the exception just mentioned, the same
conclusion has emerged in this section as in the previous
sections: an HIV test cannot permissibly be performed
without the informed consent of the person tested, in any
case in which that consent can be sought.
We are most grateful to the other members of the
Committee for the lively and interesting discussions that led
to the formulation and unanimous acceptance of these
guidelines.
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Objective: To establish an ongoing active surveillance
programme for acute respiratory infections in general, and
influenza in particular.
Design: A network of 16 sentinel primary health care
providers furnished morbidity information and clinical
specimens for virus characterisation supplemented by
school absenteeism and regional mortality data.
Setting: General practices, hospital outpatient
departments and staff clinics in the Witwatersrand area.
Participants: Subjects treated for acute respiratory
infections by 7 general practitioners, 1 specialist
pulmonologist,4 paediatric outpatient departments, 1 mine
hospital and university, factory and institutional staff clinics.
Absenteeism data were obtained from 8 primary and 6 high
schools in the region (representing 9 000 pupils}.
Outcome measures: Morbidity information and strain
characterisation of influenza isolates as well as other viral
respiratory pathogens, school absenteeism, seasonal
excess mortality.
Results: The most sensitive indicator of influenza activity
was virus isolation, which gives an earlier warning signal
of an impending epidemic than morbidity or absenteeism
parameters. Both morbidity and school absenteeism
provided quantitative indicators of the severity of the
epidemic. Mortality from all causes showed characteristic
winter increases in the 65-year-old and older population
which were not seen in younger individuals. Circulating
influenza viral strains matched the strains recommended
for the vaccine in 1991 and 1992, but not in 1993.
Conclusions: The course aJ'}d extent of the annual winter
influenza epidemic can be charted by means of an active
surveillance programme, with sentinel primary health care
providers furnishing morbidity data and c1inical'material
from which virus isolations can be made. Antigenic
characterisation of the isolates demonstrated that
circulating strains may not match recommended strains in
northern hemisphere-formulated vaccines and stresses
the need for a southern hemisphere vaccine formulation
for South Africa. Absenteeism information provides an
indicator of the impact of influenza on the economy and
excess mortality data emphasise the need for routine
immunisation of the elderly.
S Atr Med J 1994; 84: 674-678.
Influenza is an enigmatic disease. The virus is one of the
most contagious of all infectious organisms, and a new
strain of influenza can appear and spread with dramatic
swiftness causing acute pandemics of vast proportions.
However, the epidemics generally last no longer than 12
weeks and affect no more than 50% of susceptibles in a
population before mysteriously disappearing. Not
surprisingly, outlandish theories of the origin of influenza
have been published, such as Hoyle and Wickramasinghe's
hypothesis (quoted by Henderson and Perry)' that new
influenza strains arise from virus-bearing comets which
continuously bombard Earth.
At a more down-to-earth level, influenza remains one of
the major causes of morbidity and mortality in humans. In
the USA up to 20 000 deaths may be ascribed to the virus
and in major epidemic years this figure may even exceed
40 000 2 The cost of epidemics is staggering - in the USA
alone, annual productivity losses have been estimated at
over $700 million, and direct hospitalisation costs exceed
$300 million!
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Active surveillance programmes have been established in
many developed countries in an attempt to monitor influenza
epidemics,' and the World Health Organisation itself
maintains a network of over 120 national reference
laboratories throughout the world. These programmes have
two objectives.
The first is to obtain influenza virus isolates for antigenic
characterisation so that tailor-made vaccines with
corresponding antigens can be prepared annually. The
second is to quantify the extent and chart the course of the
epidemic as well as anticipate the course that it is likely to
take, so that appropriate interventions can be planned.
The influenza laboratories of the National Institute for
Virology serve as one of the National Institutes of Influenza
of the WHO. The Viral Watch Programme of the Institute was
established in 1984 to obtain influenza isolates and measure
influenza epidemics in this country! Over the past 2 years,
parameters of influenza activity such as mortality data and
respiratory morbidity indices have been added to the
programme's activities. In this article the value of the
programme in charting and forecasting the course of
influenza epidemics, particularly over the past 2 years, is
reviewed.
Patients and methods
Structure of the Viral Watch
Programme
In 1993 the Witwatersrand Viral Watch Programme
comprised 16 centres - a mine hospital, 4 paediatric
outpatient departments, 7 general practitioners, 1 specialist
pulmonologist, a university students' clinic, a factory clinic
and the staff clinic of the National Institute for Virology. The
centres represent a cross section of socio-economic
classes, age and race groups, and institutionalised and non-
institutionalised individuals. Patients are selected by Viral
Watch doctors on the basis of clinical presentation of acute
respiratory symptoms with or without pyrexia, rather than on
the surveillance definition of influenza of the WHO.' A throat
swab is taken from each patient and sent in transport
medium to the laboratory within 24 hours, as described
previously' During 1993, 13 of the Viral Watch centrE;ls also
maintained a register of all patients with any acute
respiratory symptoms. A weekly acute respiratory morbidity
index (ARMI) was calculated by division of the total number
of incidents per week by the number of participating
centres.
Indirect indices of influenza activity
In addition to the ARMI data provided by the Viral Watch
Programme, other parameters examined were school
absenteeism and mortality data. School absenteeism has
been monitored annually since 1987. In 1993, 9 000 pupils
in 8 primary schools and 6 high schools were monitored.
The schools were telephoned on a weekly basis for the
number of pupils absent each week. A weekly absenteeism
rate per 1 000 pupils was calculated by the formula (number
absent.,. total number of pupils) x 1 000. Monthly mortality
figures for 1992 and 1993 were from two old age institutions
in Johannesburg and monthly mortality rates for the
municipal region of Johannesburg were kindly supplied by
the Johannesburg City Health Department.
Virus isolation and typing
Specimens were processed and typed as described
previously' except that MOCK cells were now used for tissue
culture isolation instead of the vervet monkey kidney cells
and HeLa cells used previously. All specimens were
inoculated intra-amniotically into 12-day-old embryonated
eggs and MOCK cell cultures. The eggs were incubated for
3 days at 34°C and amniotic fluid was examined by
haemagglutination (HA), with 0,5% guinea pig and fowl red
blood cell suspensions in 0,85% saline. Positive fluid was
inoculated into the chorio-allantoic membrane of 10-day-old
embryonated eggs and incubated for 2 days at 34°C.
Negative fluid was re-passaged intra-amniotically in 12-day-
old embryonated eggs before being discarded as negative.
Specimens inoculated into MOCK cell cultures in Eagle's
MEM supplemented with 2% fetal calf serum were
incubated for 21 days at 33°C and tested for HA with guinea
pig cells as above.
Chorio-allantoic or tissue culture fluid was typed by HA
inhibition, with reference sera kindly' supplied by Or J.
Skehel of the WHO Influenza Centre, National Institute for
Medical Research, Mill Hill, London. The sera were first
treated with receptor-destroying enzyme (Phillips Duphar) in
a 1:6 dilution, serially doubly diluted and then mixed with an
equal volume of the allantoic fluid or tissue culture fluid
containing 8 HA units, and incubated at room temperature
for 1 hour. A 0,5% suspension of fowl red blood cells in
0,85% saline was added and after 45 minutes at room
temperature the HA inhibition titre was measured as the
highest dilution giving complete inhibition of HA. Positive
isolates were also sent to Or J. Skehel for confirmatory
typing.
Results
In 1991 and 1992 virus isolation was more efficient from
actively recruited (Viral Watch) specimens derived mainly
from the community (77 of 235 specimens (32%) in 1991
and 82 of 236 specimens (35%) in 1992) compared with
routine clinical specimens derived mainly from hospitalised
patients (42 of 217 (19%) in 1991 and 27 of 148 specimens
(18%) in 1992). In 1993, however, isolation rates from Viral
Watch (43 of 209 (21 %)) and routine clinical specimens (30
of 130 (23%)) were similar. In 1992, which was anecdotally
reported by the sentinel physicians to be a 'severe' year,
isolations commenced unusually early in April and continued
for a prolonged time - until September, in contrast to the
anecdotally 'milder' 1993 season when isolates were made
in a more restricted period of time - from June until August
(Fig. 1). The influenza strains isolated and typed by the WHO
reference centre in London are shown in Table I together
with the WHO recommended vaccine strains for the
preceding northern hemisphere winter which were also used
for the following winter season for vaccines in South Africa.
In 1991 and 1992 all the influenza isolates matched the
recommended vaccine strains. However the 1992 - 1993
recommended strains which were used for the 1993
SAMJ Volume 84 No. 10 October 1994
vaccines in South Africa were discordant in respect of H3N,
influenza strain; the recommended H3N, vaccine strain was
thus A/Beijing/353/89-like whereas all the H3N, isolates







The weekly school absenteeism rates for 1992 and 1993
and the ARMI for 1993 are shown in Fig. 1. In both 1992 and
1993 virus isolation proved to be a considerably more
sensitive indicator of the influenza epidemic. In 1992, virus
isolates commenced some 6 weeks before the rise in the
weekly absenteeism rate and the peak of virus isolation in
week 26 preceded by 3 weeks the peak of absenteeism.
Similarly, in 1993, virus isolations commenced some 3
weeks before the absenteeism peak. In both years biphasic
absenteeism curves were observed, with a second peak
occurring about 5 - 6 weeks after the first and coinciding
with a second round of virus isolation. The curve of the
ARMI for 1993 approximated the absenteeism curve
although it peaked about 2 weeks earlier (Fig. 1).
Fig. 1. Influenza isolations, and absenteeism and morbidity data












Fig. 2. Mortality data in the Johannesburg municipal area
supplied by the Department of Health, Housing and Urbanisation
of the City of Johannesburg.
Jan Feb Mar Apr May Jun Jul Aug Sep Qct Nov Dec
Months
Mortality figures for the two old age institutions monitored
are shown in Table 11. Although there was a tendency for
increased mortality in the winter months, these did not
appear to be significant because of the small numbers
involved. Both institutions had also extensively immunised
their residents - approximately 75% each for both
institutions. The monthly mortality rates for the municipal
area of Johannesburg are shown in Fig. 2 and demonstrate
a clear winter increase in the over-65-year age group,
peaking in June/July, while the curve for the 15 - 64-year
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Table I. Concordance of vaccine recommendations with influenza
virus isolates
Year WHO vaccine strain
recommendations
_ Isolates
---a- Actual absentee rate
---* Acute respiratory morbidity index (ARMI)
·Variant strains antigenicaJly very similar to corresponding vaccine strain.
1990-1991 recommendations"













41 x /Taiwan/1/86* (H,N,)
1 x A/Singapore/6/86 (H,N,)
5 x B/Panama/45/90*
39 x AlWashington/15/91 * (H,N,)
4 x AlHong Kong/25/90* (H,N,)
2 x A/Beijing/353189 (H,N,)
5x A/England/261/91* (H,N.)
24 x B/Quingdao/1 02191 *
1 x BNictoria/2187
21 x A/Beijing/32192 (H,N,)-like
3 x B/Panama/45/90
Table 11. Mortality figures from two old-age institutions
Institution A (N= 570) Institution B (N = 457)
Month 1992 1993 1992 1993
J 12 7 1 1
F 7 8 5 0
M 12 8 1 2
A 5 11 1 1
M 12 12 2 2
J 18 16 3 3
J 25 12 7 3
A 12 10 0 5
S 7 10 2 2
0 8 11 3 2
N 10 8 0 2
D 5 15 3
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Discussion
Influenza surveillance programmes have been established in
many countries. Some of them, e.g. those of the Centers for
Disease Control in Atlanta and the Influenza Research
Center in Houston in the USA," the GROG (Regional
Influenza Surveillance Group) in France,' the 'spotter'
physician network of the Royal College of General
Practitioners in the UK," and the Brussels Institute of
Hygiene and Epidemiology in Belgium" have developed
programmes of considerable size and sophistication with
large numbers of 'spotter' physicians reporting relatively
detailed data to central processing units. The WHO has
appealed for as many countries in the world as possible to
establish influenza surveillance programmes and possibly
network with each other through an electronic database. 'o
There are 4 major objectives of an influenza surveillance
programme. The first is to be able to have an early detection
system of an influenza outbreak so that the health care
system can be adequately prepared. The second is to
facilitate the estimation of the likely impact of a forthcoming
epidemic. The third is to collect influenza isolates both for
outbreak and patient diagnostic purposes, as well as to
provide strains for antigenic analysis for planning the
composition of vaccine. The last is to be able to delineate
groups that will be at special risk for influenza and its
complications so that they can be earmarked for vaccination
if they are not already on the existing recommended list for
vaccination.
The structures of influenza surveillance programmes vary
from country to country although in general most of the
monitoring, parameters are similar. These parameters vary
intrinsically in sensitivity and specificity, and their reliability
depends on the enthusiasm of the sentinel doctors who
collect the data as well as the representativeness of the
surveillance programmes.
Virus isolation remains the cornerstone of all influenza
surveillance programmes. The simultaneous isolation of
influenza virus and monitoring of non-viral parameters, such
as respiratory morbidity, are the only guarantee of the
specificity of the programme given the nonspecificity of
clinical presentation of influenza. In addition, virus isolation
was shown to be the most sensitive of all parameters,
preceding the rise in other parameters by several weeks.·,'·9
Several of the surveillance programmes have also added
serological investigations: blood specimens are taken before
and after an epidemic to determine the prevalence of
significantly increased titres in paired sera, which is usually
determined by the haemolysis-in-gel technique.·"'" In our
Viral Watch Programme virus isolation was also shown to be
the most sensitive of the monitoring parameters with
detection of virus preceding the increase in absenteeism by
3 - 6 weeks. The diagnostic value of virus isolation was also
shown by the demonstration that the second phase of the
epidemic in both 1992 and 1993 was coincident with the
second round of influenza virus isolation.
The value of virus isolation in obtaining strains which can
be characterised for the planning of vaccine formulation was
shown by comparison of virus isolations each year with the
vaccine formulations (Table I). The strains which are
incorporated into South African vaccines are those
recommended for the northern hemisphere winter by the
SAMJ
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WHO for the preceding winter season 6 months previously.
In most years new viral strains initially circulate during winter
in the more populous northern hemisphere and then move
down to the southern hemisphere winter 6 months later.
Thus, the vaccine formulation would usually correspond to
the circulating viral strains in South Africa and this indeed
occurred in 1991 and 1992. However, in 1993 the vaccine
formulation for the 1992/93 northern hemisphere season
contained A/Beijing/353/89 as its H3N2 strain, while the H3N2
strain which actually circulated in South Africa was a new
strain which was antigenically significantly different,
A/Beijing/32/92. This emphasises the need for a southern
hemisphere influenza vaccine manufacturing facility which
can rapidly manufacture vaccines using strains
corresponding to those circulating in this hemisphere.
The measurement and charting of respiratory morbidity
are subject to considerable error depending on the degrees
of indirectness of the parameters that are being measured.
The WHO clinical surveillance definition of influenza is that
of an acute febrile (~ 38°C) respiratory .illness usually
accompanied by prostration and cough, with or without
myalgia or sore throat. lO This has led to considerable
underdiagnosis3either because episodes do not come to
medical attention, diagnostic criteria are imprecise or, as we
found, the imposition of complex questionnaires dampens
the enthusiasm of busy sentinel physicians. More
streamlined morbidity indicators such as total respiratory
illness which may, at first sight, appear to be less specific,
turn out, in practice, to be more accurate and reliable
indicators of the influenza disease burden. Indirect
indicators, such as absenteeism, form a part of all influenza
surveillance programmes because these data are relatively
easy to obtain. School absenteeism may provide an earlier
alerting signal of an influenza epidemic compared with adult
worker absenteeism because epidemics of respiratory
infections in children always precede those in adults. It was
demonstrated over 40 years ago that the incidence of acute
respiratory infections was twice as high in adults who lived
with school age children than in adults who did not." Other
indirect parameters used include visits to hospitals or
emergency rooms3.•.' and consumption of pharmaceuticals,
such as cough preparations, decongestants, antihistamines
and antibiotics.' Each of these has a similar value as an
adjunct to the composite picture of an influenza epidemic.
These non-virological parameters can, however, be
misleading with regard to influenza activity, in the absence of
confirmation by virus isolation.·
Mortality has been used for'many years to estimate the
impact of influenza, especially in the elderly population.
Excess mortality, Le. the number of deaths recorded in
excess of the number expected on the basis of past
experience, is commonly used as an indicator of the severity
of influenza' It has been shown, however, that methods
used both to predict baseline as well as to record excess
mortality, considerably underestimate the effects of influenza
on mortality.3.' Seasonal mortality figures from all causes are
probably a better indicator of influenza activity than influenza
mortality itself.9The mortality rates in Johannesburg
demonstrated a clear winter peak in the over 65-year-old
population, confirming that this group should be routinely
immunised against influenza. In order to use excess
mortality as a measure of the impact of influenza, mortality
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rates over many years need to be utilised to determine
baseline as well as excess mortality levels. In our study
mortality figures on their own over the past few years
contributed little to our knowledge of the extent of influenza.
An epidemic of influenza is diagnosed on both virological
criteria (the proof of the presence of influenza virus) together
with epidemiological criteria (based on the presence of these
nonspecific indicators). A number of definitions of an
epidemic or an epidemic threshold have been devised. For
example, the rise of the monthly incidence of influenza-like
illness beyond 400 per 100 000 inhabitants'6 or the isolation
• of influenza from at least 10% of submitted samples,7 or an
excess of cases of influenza-like illness and nonspecific
acute respiratory illness for 2 consecutive weeks above the
epidemic threshold"
The success of the influenza surveillance programme
depends directly on the interest and enthusiasm of the
sentinel doctors and the programme is an example par
excellence of how primary care physicians and biomedical
laboratories can co-operate and collaborate in a particularly
important preventive medical venture.
Our sincere thanks to all the sentinel doctors who assisted
so enthusiastically with the Witwatersrand Viral Watch
Surveillance Programme, as well as the principals and
secretaries of all the schools included in the absenteeism
surveillance programme. We would also like to thank Ms
Magda de Beer of the Department of Health, Housing and
Urbanisation of the City of Johannesburg, and Or J. Lundie
and Sr E. Joss for providing mortality data for the two
homes for the aged studied.
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G. Maartens, S. J. Lewis, C. de Goveia, C. Bartie,
D. Roditi, K. P. Klugman
Objectives. To assess the proportion of cases of community·
acquired pneumonia caused by 'atypical' bacteria, inclUding
the recently discovered Chlamydia pneumoniae, and to
compare the clinical, radiographic and laboratory features of
patients with and without 'atypical' bacteria.
Methods. A prospective serological study was carried out
on consecutive adult pneumonia patients from July 1987 to
July 1988. Acute and convalescent sera were tested in
batches for antibodies against Legionella pneumophila
serogroup 1, C. pneumoniae, Chlamydia psittaci, Coxiella
burnetii (phase-2 antigen) and Mycoplasma pneumoniae
(lgG and IgM). Records and chest radiographs were
examined retrospectively.
Results. Acute and convalescent sera were available from
113 patients. The records of 4 patients could not be traced
and 17 patients did not fulfil the inclusion criteria. Thirty-two
of these 92 patients (35,9%) were found to be infected with
'atypical' bacteria. The two most common organisms were
C. pneumoniae (20,7%) and L. pneumophila (8,7%). There.
were no differences in the clinical and radiographic features
of patients with and without 'atypical' bacteria. Clinicians
prescribed erythromycin or tetracyclines with equal
frequency in the two groups.
Conclusions. 'Atypical' bacteria, especially C.
pneumoniae, are a common cause of community-acquired
pneumonia in adults in South Africa. This is the first
demonstration of an aetiological role of C. pneumon.iae in
this country. We confirmed the finding of other studies that
there are no clinical, radiographic or laboratory features
characteristic of 'atypical' bacterial infection in hospitalised
patients. This has major implications for therapy, as these
organisms respond to erythromycin and tetracyclines, but·
not to ~-Iactam antibiotics.
S Afr Med J 1994; 84: 678-682.
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